Home » Authors » James Etheridge

Articles by James Etheridge

Transgene In Line For €10M Milestone On CIN Compound

June 6, 2007

By James Etheridge

Pharmaxon Obtains Mimetic Peptide For Cell Mobility Drugs

June 6, 2007

By James Etheridge

Pharmaxon Obtains Mimetic Peptide For Cell Mobility Drugs

June 6, 2007

By James Etheridge

Transgene In Line For €10M Milestone On CIN Compound

June 6, 2007

By James Etheridge

No Abstract

Cellectis Reaches Milestone In Bayer CropScience Deal

May 30, 2007

By James Etheridge

BT Pharma Raises €1.3M To Advance ProCervix

May 30, 2007

By James Etheridge

BT Pharma Raises €1.3M To Advance ProCervix

May 30, 2007

By James Etheridge

No Abstract

Cellectis Reaches Milestone In Bayer CropScience Deal

May 30, 2007

By James Etheridge

Eurofins Scientific Opening Labs In Colorado, Singapore

May 16, 2007

By James Etheridge

Cellectis Licenses Technology For Homologous Recombination

May 16, 2007

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 11, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 11, 2024.
Boryung invests $10M in Intuitive Machines for outer space R&D
BioWorld
Following its $60 million investment in Axiom Space Inc. last year, Boryung Co. Ltd. made a $10 million private placement in Intuitive Machines Inc. to grow its...
Phase II Huntington’s tie-up with Novartis could edge $3B for PTC
BioWorld
PTC Therapeutics Inc. said a “highly competitive process with several parties involved” led to the deal centered on the firm’s Huntington’s disease program with...
Elevar nabs Relay’s FGFR2 rare cancer drug in $500M deal
BioWorld
Elevar Therapeutics Inc. will license Relay Therapeutics Inc.’s “NDA-ready” bile duct cancer therapy, lirafugratinib (RLY-4008), through a potential $500 million...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.